Lakestar, a venture capital firm, led a €60m Series A round in Neko Health, a health-tech company, with participation from Atomico and General Catalyst. "Healthcare costs are spiraling out of control. We believe preventive health will be key to reversing this trend. Doctors today just don't have enough time or resources to focus on prevention. This leads to many health problems going unnoticed until they get really serious, causing a lot of pain and putting a massive strain on the healthcare system. We've demonstrated that our unique approach to this problem resonates with people – that there's a genuine need and desire for this change. This strong demand is what's driving us to expand our horizons. To accelerate this, we're partnering with external investors for the first time. It's time to create the healthcare future we want, for ourselves, and for future generations,” Hjalmar Nilsonne, Neko Health Co-Founder and CEO.